Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results

Table 3 Analysis of Banff scores at diagnosis

	PE-IVIG-RTX group (n = 9)	Control group (n = 12)	P-value
Chronic glomerulopathy (cg)	2 (1-3)	1.5 (0-3)	0.792
Glomerulitis (g)	2 (1-3)	2 (0-3)	0.23
Peritubular capillaritis (ptc)	1 (0-2)	0.5 (0-3)	0.122
Microvascular inflammation (g + ptc)	3 (2-5)	2.5 (2-3)	0.219
Interstitial inflammation (ci)	1 (0-3)	1 (0-2)	0.624
Tubular atrophy (ct)	0 (0-1)	1 (0-1)	0.04
Chronicity score (ci + ct)	1 (0-3)	2 (0-3)	0.497
Arteriolar hyaline thickening (ah)	2 (0-3)	2 (0-3)	0.075
C4d+, n (%)	7/9 (77.8)	7/12 (58.3)	0.35
C4d score	2 (0-3)	1 (0-3)	0.831

Data are expressed as median (min-max).